INTEGRATED BIOPHARMA INC Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year
INTEGRATED BIOPHARMA INC (INBP) had Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year of $49.00 thousand as of 2015-12-31, per its 10-Q filed 2016-02-19.
Discontinued › Notes › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear · last filed 2016-05-13
- 2015-12-31: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $49.00K.
- 2015-09-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $73.00K.
- 2015-06-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $24.00K.
- 2015-03-31: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $34.00K.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year |
|---|---|
| 2015-12-31 | $49.00K 10-Q · filed 2016-02-19 |
| 2015-09-30 | $73.00K 10-Q · filed 2015-11-05 |
| 2015-06-30 | $24.00K 10-Q · filed 2016-05-13 |
| 2015-03-31 | $34.00K 10-Q · filed 2015-05-14 |
| 2014-12-31 | $68.00K 10-Q · filed 2015-02-17 |
| 2014-09-30 | $103.00K 10-Q · filed 2014-11-07 |
| 2014-03-31 | $34.00K 10-Q · filed 2014-05-14 |
| 2013-12-31 | $68.00K 10-Q/A · filed 2014-02-13 |
| 2013-09-30 | $103.00K 10-Q · filed 2013-11-14 |
| 2013-03-31 | $34.00K 10-Q · filed 2013-05-15 |
| 2012-12-31 | $68.00K 10-Q · filed 2013-02-19 |
| 2012-09-30 | $102.00K 10-Q · filed 2012-11-19 |